"Medical cost inflation after the rupee devaluation in 2018 and emerging
price controls on procedures and implants will continue to be in the
range of 20 per cent to 24 per cent in 2019."
The issue of leverage is haunting many players in the healthcare sector
in India. Leverage to hospitals has rapidly increased and is at an
all-time high of around 4.5 times of EBITDA.
HOT STOCKS
NSE
BSE
Stay informed about the best performers in Nifty 50. Stocks whose intraday price rose from their previous close are called gainers